Clinical trial · Interventional
Exercise Intervention for Cancer Patients
Exercise Intervention for Cancer Patients to Increase Physical Activity During Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Exhausting chemotherapy, adverse effects of chemotherapy and a lack of information on the benefits of physical exercise are the among the reasons for reduced physical exercise among cancer patients during chemotherapy courses. According to best current knowledge only about 10% of cancer patients in Finland are physically active during cancer treatment. In addition, only 20-30% are physically active after recovery from the treatments (Pylkkänen, 2015). There is only little awareness about the benefits of physical activity during cancer treatments. The purpose of the exercise intervention study is to increase the physical activity of patients who are on chemotherapy. The study is a pilot trial and has no control group. Internationally, exercise interventions have been studied among cancer patients on treatment for decades. The American College of Sports Medicine (ACSM) recommends that cancer patients should have 150 minutes of endurance exercise per week and at least two bouts of muscle strength exercise per week. Consequently, the exercise intervention study will have a combination of muscle power and endurance training. To reach the weekly recommended level of exercise, the cancer patients in the study will additionally have a weekly home training program containing preferentially endurance training. A literature search shows that no studies on exercise interventions during cancer treatment have been published in Finland. Thus, this thesis carries the wider implication of increasing the general knowledge on the importance of physical activity of cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise intervention for cancer patients to increase physical activity during chemotherapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Exercise intervention
- description
- The duration of the exercise intervention is eight (8) weeks. There will be guided endurance and muscle power training two (2) time weekly. The participants will also be provided with one training program per week for use at home. Data on training at home and other items of physical activity is recorded in a diary.
- interventionNames
- Behavioral: Exercise intervention for cancer patients to increase physical activity during chemotherapy
Primary outcomes (2)
- measure
- physical activity changes in diary
- timeFrame
- 0 and 8 weeks,
- description
- Does this exercise intervention model works for cancer patients to increase the amount of physical activity and to achieve the cancer patients exercise recommendations? (especially home-exercising)
- measure
- questionnaire-feedback from cancer patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * cancer patients in the age of 18-70 * in the early phase of chemotherapy * first line chemotherapy * active way of treating cancer * solid tumor (breast cancer, prostata cancer, colon cancer and melanoma) * Finnish-speaking * z=0-1 (no aids) * capable travelling to University hospital for 8 weeks twice a week * normal or poor physical activity background Exclusion Criteria: * exercise contraindications, like severe respiratory or circulatory system disease (eg. heart attack \<3) * brain or bone metastasis * heterogenous group (max 4 patients per cancer diagnose) * thrombocytopenia * leukocytopenia * immuno-oncological treatments * really "athlete patients"
References
Publications (0)
Data not yet available